These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3140572)

  • 41. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
    Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
    Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
    Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Premenstrual symptoms in women with premenstrual asthma.
    Ensom MH; Chong E; Carter D
    Pharmacotherapy; 1999 Apr; 19(4):374-82. PubMed ID: 10212006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progesterone treatment of premenstrual tension--a double blind study.
    Andersch B; Hahn L
    J Psychosom Res; 1985; 29(5):489-93. PubMed ID: 3906106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT.
    Smitz J; Devroey P; Camus M; Deschacht J; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1988 Jul; 3(5):585-90. PubMed ID: 3139698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.
    Mezrow G; Shoupe D; Spicer D; Lobo R; Leung B; Pike M
    Fertil Steril; 1994 Nov; 62(5):932-7. PubMed ID: 7926137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Adv Exp Med Biol; 1999; 467():85-8. PubMed ID: 10721042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome.
    Maddocks S; Hahn P; Moller F; Reid RL
    Am J Obstet Gynecol; 1986 Mar; 154(3):573-81. PubMed ID: 3513587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progesterone for premenstrual tension.
    Norris RV
    J Reprod Med; 1983 Aug; 28(8):509-16. PubMed ID: 6355465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
    Doll H; Brown S; Thurston A; Vessey M
    J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
    Thys-Jacobs S; Starkey P; Bernstein D; Tian J
    Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study.
    Gerhardsen G; Hansen AV; Killi M; Fornitz GG; Pedersen F; Roos SB
    Adv Ther; 2008 Jun; 25(6):595-607. PubMed ID: 18568441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H; Jung C; Taubert HD
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical trial of naltrexone in premenstrual syndrome.
    Chuong CJ; Coulam CB; Bergstralh EJ; O'Fallon WM; Steinmetz GI
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):332-6. PubMed ID: 3043289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW; Sondheimer SJ; Rickels K
    Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome.
    Taskin O; Gökdeniz R; Yalcinoglu A; Buhur A; Burak F; Atmaca R; Ozekici U
    Hum Reprod; 1998 Sep; 13(9):2402-5. PubMed ID: 9806257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.
    Sundblad C; Modigh K; Andersch B; Eriksson E
    Acta Psychiatr Scand; 1992 Jan; 85(1):39-47. PubMed ID: 1546547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endometrial histology during intermittent intranasal luteinizing hormone-releasing hormone (LH-RH) agonist sequentially combined with an oral progestogen as an antiovulatory contraceptive approach.
    Lemay A; Jean C; Faure N
    Fertil Steril; 1987 Nov; 48(5):775-82. PubMed ID: 2959569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.